iRhythm Technologies Inc (IRTC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
iRhythm Technologies Inc stock (IRTC) is currently trading at $121.79. iRhythm Technologies Inc PS ratio (Price-to-Sales) is 5.13. Analyst consensus price target for IRTC is $211.43. WallStSmart rates IRTC as Sell.
- IRTC PE ratio analysis and historical PE chart
- IRTC PS ratio (Price-to-Sales) history and trend
- IRTC intrinsic value — DCF, Graham Number, EPV models
- IRTC stock price prediction 2025 2026 2027 2028 2029 2030
- IRTC fair value vs current price
- IRTC insider transactions and insider buying
- Is IRTC undervalued or overvalued?
- iRhythm Technologies Inc financial analysis — revenue, earnings, cash flow
- IRTC Piotroski F-Score and Altman Z-Score
- IRTC analyst price target and Smart Rating
iRhythm Technologies Inc
📊 No data available
Try selecting a different time range
Smart Analysis
iRhythm Technologies Inc (IRTC) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth, institutional own.. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
iRhythm Technologies Inc (IRTC) Key Strengths (3)
111.61% of shares held by major funds and institutions
Strong revenue growth at 27.10% annually
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
iRhythm Technologies Inc (IRTC) Areas to Watch (5)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Very expensive at 25.1x book value
Premium valuation at 5.1x annual revenue
Supporting Valuation Data
iRhythm Technologies Inc (IRTC) Detailed Analysis Report
Overall Assessment
This company scores 29/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 8.3/10) while 5 fall into concern territory (avg 1.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Revenue Growth, Market Cap. Growth metrics are encouraging with Revenue Growth at 27.10%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Some valuation metrics including Price/Sales (5.13), Price/Book (25.12) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -36.60%, Operating Margin at 4.20%, Profit Margin at -5.96%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -36.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 27.10% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Profit Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
IRTC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
IRTC's Price-to-Sales ratio of 5.13x sits near its historical average of 5.25x (43th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 11% below its historical high of 5.79x set in Mar 2026, and 5% above its historical low of 4.89x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~5.8x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for iRhythm Technologies Inc (IRTC) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
iRhythm Technologies Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 747M with 27% growth year-over-year. The company is currently unprofitable, posting a -6.0% profit margin.
Key Findings
Revenue growing at 27% YoY, reaching 747M. This pace significantly outperforms most MEDICAL DEVICES peers.
Generating 14M in free cash flow and 26M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -6.0% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Growth sustainability: can iRhythm Technologies Inc maintain 27%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact iRhythm Technologies Inc.
Bottom Line
iRhythm Technologies Inc offers an attractive blend of growth (27% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About iRhythm Technologies Inc(IRTC)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
iRhythm Technologies, Inc., a digital healthcare company, offers ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company is headquartered in San Francisco, California.